The Cancer Consortium

Cancer News & Information Center

Sunday, October 25th, 2026

Menu

  • Home
  • Members
    • Travera
    • Soligenix (SNGX)
    • NuView Life Sciences
  • News
    • MEMBER NEWS
    • FINDINGS
    • INDUSTRY
  • INTERVIEWS
    • CEOs
    • KOLs
  • Cancer Types
    • Breast Cancer
    • Cervical Cancer
    • Head and Neck Cancer
  • Database
  • About
    • Altru Cancer
    • Cancer Consortium
    • Newsletter
    • Research
  • RESOURCES
    • Foundations
    • Patient Resources
    • Media Resources

HealthTronics Proposes Endocare Acquisition

By Global Cancer Consortium on August 8, 2008 • ( 1 Comment )

HealthTronics has made an unsolicited bid to buy Endocare for $26.9 million in cash. The offer represents a 20% premium over Endocare’s closing stock price on August 6th. HealthTronics’ product portfolio includes […]

Clarient Q2 Revenues Up 71%

By Global Cancer Consortium on August 7, 2008 • ( 3 Comments )

Not wanting to break a winning streak, Clarient delivered its 16th consecutive quarter of quarterly revenue growth. The company posted revenues of $16.9 million in its most recent quarter, a 71% increase […]

Rapture: AngioDynamics’ Lung Cancer Treatment Shows Promise

By Global Cancer Consortium on July 14, 2008 • ( Leave a comment )

Back in 2004, shares of Rita Medical surged as much as 67 percent after it reported positive results for its radio-frequency ablation (RFA) technology in a trial of lung cancer patients. The […]

[Quick Take] Interview with Vijay Aggarwal, CEO of Aureon Laboratories

By Global Cancer Consortium on July 8, 2008 • ( Leave a comment )

Aureon Laboratories is developing predictive and personalized cancer treatment options. Aureon employs a unique ‘systems pathology’ approach to provide personalized test results by analyzing a patient’s existing biopsy sample using molecular diagnostics, […]

Inovio Biomedical and VGX Pharmaceuticals to Merge

By Global Cancer Consortium on July 8, 2008 • ( 1 Comment )

Citing synergies, Inovio Biomedical and VGX Pharmaceuticals have announced merger plans. Inovio’s electroporation technology uses brief, controlled electrical pulses to increase cellular uptake of gene expression in DNA-based treatments; this enhances the […]

[Quick Take] Interview with Gary Levine, CFO of Bostwick Laboratories

By Global Cancer Consortium on June 30, 2008 • ( Leave a comment )

Bostwick Laboratories is a full-service laboratory specializing in uropathology. The company’s pathologists specialize in the diagnosis, treatment and subsequent management of prostate cancer, kidney disease, cancer of the bladder and other urologic […]

Clinical Study Brings iCAD’s Colon CAD Closer to Market

By Global Cancer Consortium on June 20, 2008 • ( Leave a comment )

Colon cancer is among the most preventable cancers when caught early. More than 82 million Americans are eligible for colorectal cancer screening. Currently, diagnostics are underutilized due in part to the invasive […]

[Quick Take] Interview with William Oravan, Medical Director at Maple Leaf HIFU Co.

By Global Cancer Consortium on June 18, 2008 • ( 5 Comments )

Maple Leaf HIFU Co. offers Ablatherm High Intensity Focused Ultrasound (HIFU) treatment for localized prostate cancer. During the procedure, a probe is placed into the rectum after spinal or epidural anesthesia has […]

Posts navigation

‹ Newer 1 … 69 70 71 72 73 74 75 76 77 78 79 … 84 Older ›

INTERVIEWS »

INTERVIEW: Travera CEO Clifford Reid PhD

INTERVIEW: Soligenix CEO Christopher Schaber PhD.

INTERVIEW: Biden Cancer Initiative’s Greg Simon

PROFILES »

Gray Scale Images Convert to Detailed Color Images to Better Diagnose Breast Cancer

New Technology Using Light Therapy Kills Cells with No Side Effects

Real-time, In vivo Imaging Platform to Guide Surgeon During Cancer Surgery

Image result for cancer commons

Cancer Progress Report

Altru Cancer Progress Report June 2019

Subscribe to Cancer Progress Report

 

 

About Cancer Consortium

Members of the Global Cancer Consortium believe that progress occurs through collaboration which can occur through improved information.

This news site aggregates information and profiles of the member companies and organizations.

Its Cancer Progress Report reaches thousands of investors and industry professionals.

Global Cancer Consortium

The Cancer Consortium was formed by the Altru Cancer Project to offer one place to learn about the most promising developments, technologies and companies focused on Cancer.

 

 

  • Top categories: COMPANIES / cancer / Blog / feature2 / NEWS / Featured Articles / MEMBER NEWS / feature1 / Uncategorized / Member Spotlight
  • Top tags: cancer / breast cancer / diagnostics / oncology / prostate cancer / clarient / peter winter / brain cancer / melanoma / immunotherapy
Proudly powered by WordPress | Theme: Broadsheet by Pro Theme Design.